Tags: Drug.
Trimetazidine is a drug for angina pectoris sold under the brand name Vastarel MR. Trimetazidine is described as the first cytoprotective anti-ischemic agent developed and marketed by Les Laboratoires Servier (France). Trimetazidine is an anti-ischemic (anti-anginal) metabolic agent which improves myocardial glucose utilization through inhibition of fatty acid metabolism also known as fatty acid oxidation inhibitor.
